Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey

Background Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Exist...

Cijeli opis

Bibliografski detalji
Glavni autori: Pouwels, K, House, T, Pritchard, E, Robotham, JV, Birrell, PJ, Gelman, A, Vihta, K-D, Bowers, N, Boreham, I, Thomas, H, Lewis, J, Bell, I, Bell, JI, Newton, J, Farrar, J, Diamon, I, Benton, P, Walker, AS
Format: Journal article
Jezik:English
Izdano: Elsevier 2020
_version_ 1826300241117184000
author Pouwels, K
House, T
Pritchard, E
Robotham, JV
Birrell, PJ
Gelman, A
Vihta, K-D
Bowers, N
Boreham, I
Thomas, H
Lewis, J
Bell, I
Bell, JI
Newton, J
Farrar, J
Diamon, I
Benton, P
Walker, AS
author_facet Pouwels, K
House, T
Pritchard, E
Robotham, JV
Birrell, PJ
Gelman, A
Vihta, K-D
Bowers, N
Boreham, I
Thomas, H
Lewis, J
Bell, I
Bell, JI
Newton, J
Farrar, J
Diamon, I
Benton, P
Walker, AS
author_sort Pouwels, K
collection OXFORD
description Background Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. Methods Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. Findings Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. Interpretation Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards.
first_indexed 2024-03-07T05:14:11Z
format Journal article
id oxford-uuid:dc942ce8-e68e-44e1-a33e-0a8ef1ad89f3
institution University of Oxford
language English
last_indexed 2024-03-07T05:14:11Z
publishDate 2020
publisher Elsevier
record_format dspace
spelling oxford-uuid:dc942ce8-e68e-44e1-a33e-0a8ef1ad89f32022-03-27T09:18:52ZCommunity prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection SurveyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dc942ce8-e68e-44e1-a33e-0a8ef1ad89f3EnglishSymplectic ElementsElsevier2020Pouwels, KHouse, TPritchard, ERobotham, JVBirrell, PJGelman, AVihta, K-DBowers, NBoreham, IThomas, HLewis, JBell, IBell, JINewton, JFarrar, JDiamon, IBenton, PWalker, ASBackground Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. Methods Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. Findings Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. Interpretation Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards.
spellingShingle Pouwels, K
House, T
Pritchard, E
Robotham, JV
Birrell, PJ
Gelman, A
Vihta, K-D
Bowers, N
Boreham, I
Thomas, H
Lewis, J
Bell, I
Bell, JI
Newton, J
Farrar, J
Diamon, I
Benton, P
Walker, AS
Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title_full Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title_fullStr Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title_full_unstemmed Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title_short Community prevalence of SARS-CoV-2 in England during April to November 2020: Results from the ONS Coronavirus Infection Survey
title_sort community prevalence of sars cov 2 in england during april to november 2020 results from the ons coronavirus infection survey
work_keys_str_mv AT pouwelsk communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT houset communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT pritcharde communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT robothamjv communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT birrellpj communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT gelmana communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT vihtakd communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT bowersn communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT borehami communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT thomash communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT lewisj communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT belli communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT bellji communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT newtonj communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT farrarj communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT diamoni communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT bentonp communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey
AT walkeras communityprevalenceofsarscov2inenglandduringapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey